FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC

FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC

Dan Zhang,1,2,* Li-li Han,3,* Fen Du,4,* Xiao-meng Liu,1 Jin Li,1 Hui-hui Wang,1 Ming-hui Song,1 Zeng Li,2 Guo-yin Li1 1College of Life Science and Agronomy, Zhoukou Normal University, Zhoukou, Henan, People’s Republic of China; 2Department of Oncology, Hanzhong 3201 Hospital Affiliated to...

Full description

Bibliographic Details
Main Authors: Zhang D, Han L, Du F, Liu X, Li J, Wang H, Song M, Li Z, Li G
Format: Article
Language:English
Published: Dove Medical Press 2019-11-01
Series:OncoTargets and Therapy
Subjects:
fibroblast growth factor receptor 1 (fgfr1)
acquired resistance
gefitinib
non-small-cell lung cancer (nsclc)
akt/mtor pathway
Online Access:https://www.dovepress.com/fgfr1-induces-acquired-resistance-against-gefitinib-by-activating-aktm-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/fgfr1-induces-acquired-resistance-against-gefitinib-by-activating-aktm-peer-reviewed-article-OTT

Similar Items